Impax Laboratories Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 recall — FDA D-0215-2017
Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs
Overview of recall records associated with Impax Laboratories, Inc., including dates, categories and classifications where available.
Classification mix: Class I: 1.
Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs
This page summarizes recall records in which the official source identifies Impax Laboratories, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.